SMTL ID : 4i0c.2 (1 other biounit)

The structure of the camelid antibody cAbHuL5 in complex with human lysozyme

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.95 Å

Oligo State

hetero-oligomer

Ligands

4 x CL: CHLORIDE ION(Non-functional Binders)

CL.1: 3 residues within 4Å: Chain A: R.5, K.33, Y.38 Ligand excluded by PLIP CL.3: 1 residues within 4Å: Chain A: R.101 Ligand excluded by PLIP CL.4: 6 residues within 4Å: Chain B: K.97, A.100, F.101, S.102, S.105, A.112 Ligand excluded by PLIP CL.5: 4 residues within 4Å: Chain B: G.10, S.11, Q.121, T.123 Ligand excluded by PLIP

1 x GOL: GLYCEROL(Non-functional Binders)

GOL.2: 7 residues within 4Å: Chain A: Q.58, I.59, N.60, W.64, V.99, A.108, W.109 6 PLIP interactions: 6 interactions with chain A Hydrogen bonds: A:N.60 Water bridges: A:E.35, A:Q.58, A:W.64, A:A.108, A:V.110

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

De Genst, E. et al., A nanobody binding to non-amyloidogenic regions of the protein human lysozyme enhances partial unfolding but inhibits amyloid fibril formation. J.Phys.Chem.B (2013)

Release Date

2013-10-09

Peptides

Lysozyme C: A
cAbHuL5 antibody: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

B
C

Lysozyme C

cAbHuL5 antibody

Related Entries With Identical Sequence